Key terms
About ICLR
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ICLR news
Apr 08
4:31am ET
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neurocrine (NBIX)
Apr 05
8:41am ET
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Icon (ICLR) and Teladoc (TDOC)
Apr 04
8:20am ET
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Apr 04
6:49am ET
Icon price target raised to $362 from $345 at Baird
Apr 03
4:16pm ET
Icon backs FY24 adjusted EPS view $14.50-$15.30, consensus $14.94
Apr 03
4:16pm ET
Icon CFO Brendan Brennan to leave company
Feb 26
7:40am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 23
8:30am ET
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Icon (ICLR)
Feb 23
7:22am ET
Icon price target raised to $367 from $357 at Truist
Feb 23
6:59am ET
Icon price target raised to $345 from $315 at Mizuho
Feb 23
6:34am ET
Icon price target raised to $345 from $308 at Baird
Feb 23
5:47am ET
Icon price target raised to $355 from $325 at Barclays
Feb 22
3:35pm ET
Icon’s Market and Financial Strengths Justify Buy Rating
Feb 22
5:40am ET
Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR)
Feb 22
5:12am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Icon (ICLR) and Crispr Therapeutics AG (CRSP)
Feb 21
4:22pm ET
Icon announces $500M share repurchase program
Feb 21
4:21pm ET
Icon affirms 2024 adjusted EPS outlook $14.50-$15.30, consensus $14.91
Jan 24
7:19am ET
Icon price target raised to $325 from $280 at Barclays
Jan 10
8:30am ET
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Biogen (BIIB)
Jan 10
6:51am ET
Icon price target raised to $308 from $304 at Baird
Jan 10
5:40am ET
Analysts Are Bullish on These Healthcare Stocks: Icon (ICLR), Glaukos (GKOS)
No recent press releases are available for ICLR
ICLR Financials
Key terms
Ad Feedback
ICLR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ICLR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
